|
| |
| 1 May 2008 |
 |
3-D Matrix Announces Agreement with BD Biosciences to Market Peptide Hydrogel Products to the Global Research Community. |
| 11 October 2007 |
|
3DM, Inc. is acquired by its Japanese collaborator, 3DMatrix Japan, Ltd., and accelerates its clinical application and research reagent by the support of its new parent company. |
| 1 August 2007 |
|
3DM Inc to Present at First Albany Capital Regenerative Medicine Conference in NYC |
| 16 July 2007 |
|
Robert Langer Wins National Medal of Science |
| 2 April 2007 |
|
3DM Inc. Technology Named Top Ten Emerging Technologies for 2007 by Technology Review Magazine for Nanohealing |
| 6 September 2006 |
|
3DM Inc. Welcomes Leading Cardiac and Orthopedic Clinical Researchers to its Clinical Advisory Board |
| 31 July 2006 |
|
3DM Inc. to Keynote at Dow Jones Wall Street Journal Healthcare Innovations Conference; Demonstrating the Power of Biomaterial Scoffolds in Regenerative Medicine |
| 15 March 2006 |
|
3DM Inc. to Showcase Next Generation Nanobiomaterials at 2006 Society for Biomaterials & PTEI Regenerative Medicine World Congress |
| 2 November 2005 |
|
3DM Inc. Founders Awarded $6.5million NIH Program Grant for Regenerative Medicine & Tissue Engineering Research
|
| 1 August 2005 |
|
3DM Inc. to Present on Orthopedic Biomaterials at the Dow Jones Venturewire Healthcare Ventures Conference |
| 21 July 2005 |
|
BD™ PuraMatrix™ Synthetic Hydrogels Featured in BD Biosciences Inaugural Web Seminar Series |
| 25 May 2005 |
|
3DM Inc. to Present Stem Cell Culture Benefits of PuraMatrix Hydrogels at International Society for Stem Cell Research Conference |
| 21 Feb 2005 |
|
3DM Inc. Invited to Present on Orthopedic &
Cardiac Regeneration at Windhover Convergence: Drug Device Conference |
| 28 Oct 2004 |
|
3DM Inc. Secures $1.7Million Financing For Clinical Development of PuraMatrix™ Hydrogels |
| 26 Sept 2004 |
|
3DM Inc. Launches PuraMatrix™ Hydrogels Through Worldwide Partnership with BD Biosciences |
| 8 July 2004 |
|
PuraMatrix™ Hydrogels Win Prestigious R&D100 Life Science Award: Most technologically
significant new product impacting medical & life science product launched in the past year |
| 1 March 2004: |
|
PuraMatrix™ Hydrogels Win International Awards for Biomaterial Nanotechnology & Regenerative
Medicine: Most innovative new product to impact biotechnology, drug discovery, and medical devices |
| 9 Dec 2003 |
|
3DM Inc. Launches PuraMatrix™ Synthetic Hydrogels at American Society
for Cell Biology (ASCB)Conference, Major Advance In 3-D Cell Culture and Defined Drug Discovery Assays |
| 21 Aug 2003 |
|
3DM Inc. PuraMatrix™ Synthetic Extracellular Matrix featured in journal Nature |
| |
|
| |
Nanotech helps blind hamsters see
BBC News, March 14, 2006
Nanotechnology has restored the sight of blind rodents, a new study shows. |
Hamster Study Shows Nanofibers Knit Severed Neurons Together, Restore Vision
ScientificAmerican.com, March 14, 2006 |
Brain-Healing Nanotechnology
Technology Review, March 14, 2006
A ground-breaking treatment could restore lost abilities to stroke victims and others. |
Nanotechnology May Repair Damaged Brains
Forbes.com, 03.14.06, 12:00 AM ET |
MIT Researchers Restore Vision In Rodents Blinded By Brain Damage Using Nanotechnology
Nanotechwire.com, 3/14/2006 3:45:59 PM |
Nanotech restores vision in hamsters
MSNBC, 8:02 p.m. ET March 13, 2006
Synthetic mesh may someday be used for human brain injuries |
Optic nerve regrown with a nanofibre scaffold
13 March 2006, NewScientist.com news service Paul Marks.
Optic nerve regeneration and functional return with PuraMatrix nanofibre peptide scaffolds. |
MIT researchers restore vision in rodents blinded by brain damage
Deborah Halber, News Office Correspondent, March 13, 2006
First nanotechnology solution to repair and restore brain and vision function. |
Nanomedicine's Promise Is Anything but Tiny
By Rick Weiss; Washington Post Staff Writer; Monday, January 31, 2005; Page A08
The nanofibers turn the liquid in which they are suspended into a therapeutic gel, which in experiments with cultured cells spurred neuron growth and inhibited scar formation. Moreover, rats and mice that got injections of the liquid a day after spinal cord injuries were more likely to recover the ability to walk than untreated animals. |
Chemical & Engineering News (ISSN 0009-2347): January 3, 2005
MATERIALS POTPOURRI: Regenerative medicine meets nanotechnology; Nanomaterials built from a simple family of self-assembling molecules may offer hope for treating serious injuries such as stroke and spinal cord trauma. http://pubs.acs.org/cen/nanofocus/top/83/8301materials.html |
The VC Deal Newsletter http://www.thedeal.com/NASApp/cs/CS?pagename=TheDeal/TDDArticle/
StandardArticle&bn=NULL&c=TDDArticle&cid=1098397175628 |
 Medicine
on a small scale: How molecular medicine can benefit from self-assembled
and nanostructured materials
EMBO Reports, Vol 4, Number 11 (Jan 2004) [Nanotechnology, nanomedicine, drug
delivery] |
 Biology's
New Dimension
Nature, Vol 424 (21 Aug 2003) [3D Cell Culture, Cancer Research,
NIH Funding] |
Goodbye,
Flat Biology
Nature, Vol 424 (21 Aug 2003) [Editorial on trends in cell-based
assays & biological
research] |
Self-Assembling
Peptide Hydrogel Shows Potential for Cartilage Tissue Repair
Materials Connections: Research News, Materials Research Society
(Sept. 2002) |
Molecular-scale biomimicry Nature Biotechnology 20, 30 - 31 (2002); William L. Murphy & David J. Mooney
The design of self-assembling biomaterials that mimic complex biological structures represents a considerable challenge. This is perhaps not surprising when one considers that such structures have undergone millions of years of evolutionary optimization. Fortunately for us, biomimetics research is proceeding on a rather faster time scale, as demonstrated by a recent paper in Science by Stupp and colleagues 1. They report a molecule that self-assembles into a nanostructured gel and mimics some of the key properties of the human bone extracellular matrix (ECM). Materials based on this approach may prove useful in the regeneration of bony tissues. |
New
Gel Could Lead to Cartilage Repair
ScienceNews [Chondrocyte and osteoblast growth on nanofiber scaffolds] |
Biological
Scaffold Allows Nerve Cells to Grow and Form Connections
News: Biomedical Engineering, The Whitaker Foundation (June 2000)
[Neurite outgrowth assay] |
One-Upping Nature's
Materials: Striving for designer substances that build themselves from individual
molecutles
ScienceNews (Dec. 2000) |
Biomaterials for Growing
Mammalian Cells
A to Z of Materials
The Australian Ceramic Society |
Technique
Could Improve Cartilage Repair
MIT News
|
Cartilage Repair
MIT Technology Insider
Lab News |
Scientists
and Engineers Together Revolutionizing Human Health
MIT Spectrum (Spring 2002) |
| |
|
| |
BioNanotechnology Conference, the international conference where biotech and nanotechnology converge, organized by Nano Science & Technology Institute
http://www.comppub.com/BioNano2005/ |
Windhover, the publishers of Start-Up and In
Vivo medical ventures publications and IN3 Conferences, have
created Convergence: Drug Device Summit
http://www.windhover.com/dotcom/conferences/index.asp?page=convergence |
National Academy of Sciences Conference: Designing Nanostructures at the Interface Between Biomedical and Physical Systems Pre-Conference ( September 18-19, 2004 ).
A good summary of Self-Assembling Peptide Biomaterials, Extracellular Matrix Nanostructures, and applications in Regenerative Medicine and Tissue Engineering by Samuel Stupp , Northwestern University
http://www.nyas.org/ebriefreps/main.asp?intSubsectionID=1245
http://progressive.playstream.com/nakfi/progressive/Pre-Conference/stupp/HTML/index.htm |
Cambridge Healthtech
Institute Pharmaceutical Strategy Licensing & Partnering Congress
http://www.healthtech.com/2004/lic/day1.asp |
| |
|
| |
Start-Up: Windhover's Review of Emerging Medical Ventures, 04/01/2005 , page 39
Emerging Company Profile; Convergence (Devices and Biology) ; Orthopedic Implants ; Regenerative Medicine
The field of tissue engineering has long sought a synthetic version of the extracellular matrix and 3DM Inc. may just have found the ideal synthetic nano-scaffold to fill the void. The company's founders-many of whom come from the Massachusetts Institute of Technology (MIT)-make up a "Who's Who" of biomaterials and tissue engineering. |
Tissue Engineering, Cell Therapy
and Transplantation: Products, Technologies & Market Opportunities,
2004-2014; (published April
2005) http://www.the-infoshop.com/study/med29226_tissue_engineering_toc.html
|
| Tissue Engineering, Cell Therapy and
Transplantation: Products, Technologies and Market Opportunities,
2003-2013, report S505 (published August 2003) http://www.mediligence.com/rpt-s505.htm |
| Nanotechnology & MEMS: Current
Medical Technologies, Applications & Market Opportunities, 2002-2012, report T601
(published January 2003) http://www.mediligence.com/rpt-t601.htm |
| Cell Therapy,
Tissue Engineering and Regeneration Showing Proof-of-Concept,
Encouraging Continued Investment and Acquisition, According
to New Report from MedMarket Diligence, LLC http://www.mediligence.com/PR/PR04-05.htm |
Emerging Drug Discovery Technologies: Building competitive
advantage through lab-on-a-chip, nanotechnology and RNAi
Description: Emerging Drug Discovery
Technologies: Building competitive advantage through lab-on-a-chip,
nanotechnology and RNAi, is a new report which provides an in-depth
analysis of three technological innovations that are being heralded
to revolutionize the drug discovery process by rapidly expediting
drug discovery research. This report focuses on lab-on-a-chip (LOC)
devices, nanotechnology and RNA interference drug discovery technologies
that are increasingly being used to identify novel drug targets and
to successfully reduce R&D timelines. http://www.researchandmarkets.com/reports/298295/298295.htm
Table of Contents |
| The Impact of Nanotechnology in Drug Discovery:
Global Developments, Market Analysis and Future Prospects;
NanoMarkets, Jan 2004; This
report will be of vital interest to strategic planners, marketing
managers and product development managers at all pharmaceutical,
diagnostic, life science and biotechnology companies that may
be interested in nanotechnology. This report may also benefit
individuals and investors who track advances in the evolving nanotechnology
market, including venture capitalists, healthcare equity analysts,
academic research and scientific staff.http://www.researchandmarkets.com/reportinfo.asp?report_id=227590&t=d&cat_id=4 |
Tissue Engineering: Technology, Trends, and Market Opportunities
Drug and Market Development Publishing ; September 1, 2004; 120 Pages -
Pub ID: DSMD1049331
Abstract: This Report provides an up-to-date, comprehensive analysis
of the tissue engineering industry. The Report presents an analysis
of core tissue engineering technology (cells, materials, and manufacturing)
and evaluates both the technical and market challenges and opportunities.
In addition, the Report provides a clear understanding of the complexities
of product development, the potential impact of new technical advances,
and the necessary context for business planning. This Report provides
the critical knowledge necessary to succeed in this developing market. http://www.marketresearch.com/product/display.asp?productid=1049331&xs=r |
